THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;MITOKININ LLC
发明人:
Hertz, Nicholas T.,Shokat, Kevan M.,Devita, Robert
申请号：
NZ71044414
公开号：
NZ710444A
申请日:
2014.02.11
申请国别(地区):
NZ
年份:
2020
代理人:
摘要：
Provided herein, inter alia, the present invention provides a use of a compound having a structure represented by a formula (III) or (V) useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
